50. Clinical benefit table: Zeel versus Hyalgan. Continuous outcome measures.
Study | Time | Treatment | Outcome (scale) | N of Pts | Baseline Mean | End of Study Mean | Absolute Benefit | Relative Difference |
Nahler 1998 | 1‐4 wk | T: Zeel | Pain during movement (0‐100 mm VAS) | 57 | 67 | 31 | 1 (W) | 1.6% (W) |
C: Hyalgan | 57 | 63 | 26 | |||||
Nahler 1998 | 1‐4 wk | T: Zeel | Pain at night (0‐100 mm VAS) | 57 | 33 | 9 | 4 (W) | 11.4% (W) |
C: Hyalgan | 57 | 35 | 7 |